Bai Weimin, Hao Benchuan, Meng Wenwen, Qin Ji, Xu Weihao, Qin Lijie
Department of Emergency, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.
Medical School of Chinese People's Liberation Army (PLA), Beijing, China.
Front Cardiovasc Med. 2022 Dec 15;9:1056037. doi: 10.3389/fcvm.2022.1056037. eCollection 2022.
Frailty has been recognized as an important prognostic indicator in patients with acute myocardial infarction (AMI). However, no study has focused on critical AMI patients. We aimed to determine the impact of frailty on short- and long-term mortality risk in critical AMI patients.
Data from the Medical Information Mart for Intensive Care (MIMIC)-IV database was used. Frailty was assessed using the Hospital Frailty Risk Score (HFRS). Outcomes were in-hospital mortality and 1-year mortality. Logistic regression and Cox proportional-hazards models were used to investigate the association between frailty and outcomes.
Among 5,003 critical AMI patients, 2,176 were non-frail (43.5%), 2,355 were pre-frail (47.1%), and 472 were frail (9.4%). The in-hospital mortality rate was 13.8%, and the 1-year mortality rate was 29.5%. In our multivariable model, frailty was significantly associated with in-hospital mortality [odds ratio (OR) = 1.30, 95% confidence interval (CI): 1.20-1.41] and 1-year mortality [hazard ratio (HR) = 1.29, 95% CI: 1.24-1.35] as a continuous variable (per five-score increase). When assessed as categorical variables, pre-frailty and frailty were both associated with in-hospital mortality (OR = 2.80, 95% CI: 2.19-3.59 and OR = 2.69, 95% CI: 1.93-3.73, respectively) and 1-year mortality (HR = 2.32, 95% CI: 2.00-2.69 and HR = 2.81, 95% CI: 2.33-3.39, respectively) after adjustment for confounders. Subgroup analysis showed that frailty was only associated with in-hospital mortality in critically ill patients with non-ST-segment elevation myocardial infarction (STEMI) but not STEMI ( for interaction = 0.012). In addition, frailty was associated with 1-year mortality in both STEMI and non-STEMI patients ( for interaction = 0.447). The addition of frailty produced the incremental value over the initial model generated by baseline characteristics for both in-hospital and 1-year mortality.
Frailty, as assessed by the HFRS, was associated with both in-hospital and 1-year mortality in critical AMI patients. Frailty improves the prediction of short- and long-term mortality in critical AMI patients and may have potential clinical applications.
衰弱已被公认为急性心肌梗死(AMI)患者的重要预后指标。然而,尚无研究聚焦于重症AMI患者。我们旨在确定衰弱对重症AMI患者短期和长期死亡风险的影响。
使用重症监护医学信息数据库(MIMIC)-IV的数据。采用医院衰弱风险评分(HFRS)评估衰弱情况。结局指标为住院死亡率和1年死亡率。使用逻辑回归和Cox比例风险模型研究衰弱与结局之间的关联。
在5003例重症AMI患者中,2176例无衰弱(43.5%),2355例为衰弱前期(47.1%),472例为衰弱(9.4%)。住院死亡率为13.8%,1年死亡率为29.5%。在我们的多变量模型中,作为连续变量(每增加五分),衰弱与住院死亡率[比值比(OR)=1.30,95%置信区间(CI):1.20 - 1.41]和1年死亡率[风险比(HR)=1.29,95%CI:1.24 - 1.35]显著相关。当作为分类变量评估时,在调整混杂因素后,衰弱前期和衰弱均与住院死亡率(OR分别为2.80,95%CI:2.19 - 3.59和OR = 2.69,95%CI:1.93 - 3.73)和1年死亡率(HR分别为2.32,95%CI:2.00 - 2.69和HR = 2.81,95%CI:2.33 - 3.39)相关。亚组分析显示,衰弱仅与非ST段抬高型心肌梗死(NSTEMI)的重症患者的住院死亡率相关,而与ST段抬高型心肌梗死(STEMI)患者无关(交互作用P = 0.012)。此外,衰弱与STEMI和NSTEMI患者的1年死亡率均相关(交互作用P = 0.447)。对于住院死亡率和1年死亡率,加入衰弱因素比仅基于基线特征生成的初始模型具有更高的预测价值。
通过HFRS评估的衰弱与重症AMI患者的住院死亡率和1年死亡率均相关。衰弱可改善对重症AMI患者短期和长期死亡率的预测,可能具有潜在的临床应用价值。